
EU member States are determined to curtail Britain’s ability to hand out State money to prized industries as a key price for agreeing a trade deal, according to senior European diplomats, opening up a major battleground in the post-Brexit negotiations, reported the Financial Times.
Brussels, whose negotiating team will be headed by Michel Barnier, will insist that the UK sticks especially closely to EU State aid rules when it kicks off what are set to be fraught future relationship negotiations with Britain soon after Brexit day on Friday, January 31.
UK Prime Minister Boris Johnson last November caused concern in Brussels when he announced plans to make it “faster and easier” for the UK government to intervene in failing industries after Brexit.
He also said he would “fundamentally change” public procurement rules to “back British business.” Britain’s former ambassador to the EU Ivan Rogers claimed the idea appeared to mimic Donald Trump’s “Buy American” policy.
But the EU sees State aid as one of the most sensitive parts of the “level playing field” of common rules and standards that it says Britain must adhere to if it wants any trade deal — and it plans to impose requirements that go far beyond those demanded of other trading partners in this area.
Full Content: Financial Times
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Meta Begins Defense After FTC Concludes Case in Landmark Antitrust Trial
May 15, 2025 by
CPI
UK Data Bill Still No Closer to Passage As Parliamentary ‘Ping-Pong’ Drags On
May 15, 2025 by
CPI
Regeneron Pharmaceuticals Awarded $271.2M in Damages Against Amgen
May 15, 2025 by
CPI
FTC Chair Proposes 15% Staff Reduction Amid Budget Constraints
May 15, 2025 by
CPI
UK Urges Antitrust Watchdog to Prioritize Growth and Clarity in Business Regulation
May 15, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas